Skip to content

Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion

Early (4th Week) Versus Late (6thweek) Interval Postpartum Copper Intrauterine Device Insertion: a Randomized Controlled Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03106805
Enrollment
0
Registered
2017-04-10
Start date
2017-07-01
Completion date
2022-03-31
Last updated
2022-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception Behavior

Keywords

intrauterine device

Brief summary

The optimal interval between pregnancies is debated, but a duration greater than 11-18 months has been suggested as reducing complications in the subsequent pregnancy. Improved birth spacing can be a key benefit use of long-acting reversible contraception, but delay to initiation can still be problematic.So women who have recently given birth can be cost-effectively targeted for family planning education and engagement because often they are already connected with health professionals

Interventions

insertion at 4th postpartum week

PROCEDURElate insertion

insertion at 6th postpartum week

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

Delivered (vaginal or Cesarean) a singleton living baby ≥28weeks gestation. Women desire birth spacing for one year or more. Women who will accept to participate in the study and follow up.

Exclusion criteria

1. Known uterine anomalies. 2. Women with previous ectopic pregnancy. 3. Presence of postpartum pyrexia. 4. Women with history of postpartum hemorrhage in the last delivery either primary or secondary. 5. Retained products of conception. 6. History of previous uterine perforation. 7. Anticipation of difficulty of subsequent follow-up with the women. 8. Women with uncontrolled diabetes and hypertension. 9. Women who wish to use other contraceptive methods.

Design outcomes

Primary

MeasureTime frameDescription
The number of participants use the device6 weeksnumber of women place the intrauterine device within 6 weeks

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026